Sammaan Capital announced that a meeting of the Securities Issuance and Investment Committee of the company is scheduled to be held on or after 20 July 2026. According to reports from Business Standard, the committee will consider and, if thought fit, approve the proposal for buyback of the USD denominated bonds. The meeting is subject to applicable laws, regulatory approvals, market conditions and terms of the respective issue documents.
The committee will evaluate the proposal for buyback of USD denominated bonds during the scheduled meeting. As reported by Business Standard, the decision will be made based on multiple factors including applicable laws, regulatory approvals, market conditions and terms of the respective issue documents. The buyback proposal represents a potential corporate action that could affect the company's debt structure and financial position, with the decision aimed at managing the company's debt profile.
The proposed buyback will be subject to applicable laws, regulatory approvals, market conditions and terms of the respective issue documents. According to the announcement, these conditions will be evaluated by the Securities Issuance and Investment Committee before any final decision is made. The committee's decision will depend on the prevailing market conditions at the time of the meeting, with the regulatory compliance ensuring the buyback follows proper legal and market standards. The intimation was made pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The potential buyback raises important questions about Sammaan Capital's overall cost of borrowing and potential impact on the company's credit rating if successfully executed. As reported by Business Standard, the company is also considering alternative debt management strategies if market conditions prove unfavorable in 2026. The filing was submitted to BSE Limited, National Stock Exchange of India Limited, India International Exchange IFSC Limited, and NSE IFSC Limited to ensure proper regulatory disclosure.
